Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Merit Medical Systems, Inc. (NASDAQ: MMSI) resulting from allegations that Merit Medical may have issued materially misleading business information to the investing public.

After the market closed on July 25, 2019, Merit Medical announced its financial and operating results for the second quarter of 2019. Merit Medical announced net income of $6.9 million, or $0.12 per share, compared to $10.9 million, or $0.21 per share for the same period in the prior year. Merit Medical’s Chairman and Chief Executive Officer, Fred P. Lampropoulos, cited “a number of factors affecting revenues and gross margins during the second quarter,” including “foreign exchange [and] slower than anticipated conversion and uptake of acquired products.” On this news, Merit Medical’s stock price fell $13.84 per share, or 25.24%, to close at $41.00 on July 26, 2019.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Merit Medical investors. If you purchased shares of Merit Medical please visit the firm’s website at http://www.rosenlegal.com/cases-register-1651.html to join the class action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or cases@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190809005277/en/